Stockreport

Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF Third quarter global net product sales of $90.3 million; 2024 guidance increased to $330 - 335 millionVolixibat granted breakthrough therapy designation for treatment of [Read more]